Pular para o conteúdo principal
Ranking Invest

LBPH - Longboard Pharmaceuticals, Inc.

Segmento: HealthcareLongboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Análise Ranking Invest

Valuation estimado
$ 94.63 Mi
Último Balanço Atualizado: 3T2024

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 275.19 Mi

Dívida Líquida

-$ 23.88 Mi

L4T

-$ 76.34 Mi

MM4T

-46978.13%

Indicadores Básicos

ROE

-27.74%

Índices de Previsibilidade

Receita Líquida

A0.00

Lucro

B0.16

Margem

A0.00

Índices de Tendência

Receita Líquida

D0.00

Lucro

G-10.44

Margem

D0.00

Índices de Endividamento

DIV/PAT

-0.09

DIV/L4T

0.31

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.